Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates

Kenvue (KVUE.N), opens new tab will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter profit.
Since its spinoff from Johnson & Johnson (JNJ.N), opens new tab last year, Kenvue has focused on its 15 priority brands and in February announced it would increase its advertising spending this year.